FIDELIS PHARMACEUTICALS

LIVE

Serial Number

86760833

Owner

FIDELIS ANIMAL HEALTH, INC.

Attorney

Frederic M. Wilf

First Use Date

Sep 1, 2015

Filing Date

Sep 18, 2015

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

FIDELIS PHARMACEUTICALS Trademark

Serial Number: 86760833 • Registration: 5039296

FIDELIS PHARMACEUTICALS is a trademark filed by FIDELIS ANIMAL HEALTH, INC. on September 18, 2015. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

FIDELIS ANIMAL HEALTH, INC. (4 trademarks)

675 HIGHWAY ONE
NORTH BRUNSWICK, NJ 08902

Entity Type: 03

FIDELIS PHARMACEUTICALS, INC. (3 trademarks)

675 US HIGHWAY ONE, SUITE B113
NORTH BRUNSWICK, NJ 08902

Entity Type: 03

FIDELIS PHARMACEUTICALS LLC (3 trademarks)

Suite B113
North Brunswick, NJ 08902

Entity Type: 16

Legal Representation

Attorney of Record

Frederic M. Wilf

230 trademarks filed View all →

Correspondence Address

Frederic M. Wilf Wilftek LLC

30 Ardmore Ave #465

Ardmore, PA 19003

UNITED STATES

Trademark Details

Filing Date

September 18, 2015

Registration Date

September 13, 2016

First Use Anywhere

September 1, 2015

First Use in Commerce

September 1, 2015

Published for Opposition

June 28, 2016

Goods & Services

Development of pharmaceutical preparations and medicines

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Sep 13, 2025 REM2

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Dec 11, 2022 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Dec 11, 2022 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Dec 11, 2022 APRE

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jun 22, 2022 ASGN

TEAS SECTION 8 & 15 RECEIVED

May 29, 2022 E815

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

May 19, 2022 ASGN

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Sep 13, 2021 REM1

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jul 7, 2020 CHAN

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 7, 2020 TCCA

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

Jul 7, 2020 EWAF

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jul 7, 2020 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jul 7, 2020 REAP

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jul 7, 2020 COAR

REGISTERED-PRINCIPAL REGISTER

Sep 13, 2016 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 28, 2016 NPUB

PUBLISHED FOR OPPOSITION

Jun 28, 2016 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 8, 2016 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

May 20, 2016 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

May 19, 2016 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 19, 2016 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 19, 2016 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 6, 2016 GNRN

NON-FINAL ACTION E-MAILED

Jan 6, 2016 GNRT

NON-FINAL ACTION WRITTEN

Jan 6, 2016 CNRT

ASSIGNED TO EXAMINER

Jan 6, 2016 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 22, 2015 NWOS

NEW APPLICATION ENTERED

Sep 22, 2015 NWAP

Related Trademarks

More from this Owner

FIDELIS

ETHIQA XR

ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML

More in Same Class

IMPACT SOURCING

CABC